Author: BusinessWire

– A smart-alert study to guide anticoagulant treatment for patients with atrial fibrillation
SEONGNAM, South Korea–(BUSINESS WIRE)–#AnticoagulantTreatment–Sky Labs, a healthcare start-up, announced that CART-I, its ring-type heart-monitoring device…

DUBLIN–(BUSINESS WIRE)–The “Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: COVID-19 Impact and Recovery” report has been added to ResearchAndMarkets.com’s offering.

The global drugs for hormonal replacement therapy market is ex…

DUBLIN–(BUSINESS WIRE)–The “Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025” report has been added to ResearchAndMarkets.com’s offering.

This report reviews about the wide spread applications of the market and how it …

The power and resolution of the Molecular Cartography™ platform is illuminating important cellular interactions in COVID-19 pathology, neurology, and developmental biology research
MONHEIM AM RHEIN, Germany–(BUSINESS WIRE)–#COVID19–Resolve Bioscien…

 Company launch and rebrand in the US reflects expert leadership in precision oncology and a new business model optimized for speed to market by hyper-targeting patient populations with unaddressed tumor mutations to match them with validated oncology…

– Targeted to Help Accelerate US and Worldwide Drug Discovery and Pre-Clinical R&D
WILMINGTON, Del.–(BUSINESS WIRE)–GemPharmatech (GPT) Co., Ltd. announced the establishment of new operations to house more than 6000 mouse models in Massachusetts…

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for ruxolitinib (Jakafi®) for treatment of ste…

NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the appointment of accomplished biotech and pharmaceutical executive, Olivi…

POTOMAC, Md.–(BUSINESS WIRE)–#AD–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to proceed by the…

SUGAR LAND, Texas–(BUSINESS WIRE)–#biopharmaceutical–Non-profit research organization Hope Biosciences Stem Cell Research Foundation (HBSCRF) gained Federal Drug Administration (FDA) authorization Friday for the nation’s first stem cell study design…